On Demand Webinars

Characterization of Residual Impurities in Gene Therapy Drug Products

Presented by Jessica Townsend, Associate Director of Analytical CMC Lead at Intellia Therapeutics and Eric S. Bishop, Vice President of Research & Development at Cygnus Technologies
26th January 2023

A Hybrid Approach to Continuous Biomanufacturing of Biosimilars

Presented by Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech and Melisa Caprio, Global Director of Upstream Field Applications at Repligen
19th January 2023

Mass Transport Modelling in support of leachable risk management

Presented by Thomas Egert, Research Scientist Pharmaceutical Contact Materials at Boehringer Ingelheim Pharma GmbH and and Jason Creasey, Managing Director at Maven E&L Ltd
17th January 2023

The Importance of Accurate Chemical Characterization of Medical Devices Extractables

Presented by Ron Brown, Toxicologist at Risk Science Consortium and Presented by Dries Cardoen, PhD, Sr. E&L Expert – Team leader at Nelson Labs
16th November 2022

Utilizing Cell Culture Platform and High-Throughput Bioreactors to Streamline Upstream Process Development and manufacturing scale-up

Presented by Sanjeev Gupta, Ph.D., Vice President and Head Advanced Biotech (Biosimilar Division), Ipca Laboratories Ltd., Mumbai-India, Vaibhav Patil Manager of Data Science, APAC at Sartorius Data Analytics and Deepak Vengovan, Manager of Field application at Sartorius Stedim Data Analytics
15th November 2022

Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review

Presented by John Duguid, Executive Director, Research & Development at Vericel Corporation and Lori Daane, Pharma Microbiology Sr. Scientific Director at bioMérieux and Mike Brewer, Director, Global Principal Consultant, Regulatory, BioProduction at Thermo Fisher Scientific
01st November 2022

Safety Evaluation on Extractables and Leachable

Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Tino Otte, Head of Sales & Consulting at Intertek
25th October 2022

Annex 1 and Environmental Monitoring Program – Implementation And Justification of The Best Practices In Routine

Presented by Presented by Benoit Ramond, Head of Microbiology & Sterile Technology at Sanofi and Laurent Leblanc, 3P Ecosytem R&D Manager at bioMérieux
19th October 2022

UNICAN: Dual capability in single use bioreactors

Presented by Presented by Ekta Mahajan, Sr. Principal Material Science Engineer at Genentech
13th October 2022

Best Practices of Downstream Protein Purification and Product Concentration

Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Director at Biocon Biologics, Sofie Östemar, Product Manager for Connected & Continuous Downstream Processing, Henrik Ihre, Ph.D. Director Strategic Technologies at Cytiva and Nigel Jackson, Principal Engineer, Bioprocessing R&D at Pall Corporation
12th October 2022